« Back to Record
Citation APA

Budde, K., Knoll, G., Curtis, J., Chan, L., Pohanka, E., Gentil, M. Á. M., Seifu, Y., Marrast, A. C., Neumayer, H., Jones, J., Staffield-Coit, C., Copley, J. B. J., Pescovitz, M., Kahana, L., Halloran, P., Shoker, A. S. A., Danovitch, G., Pelletier, R., Salvadori, M., Weir, M., Flechner, S., Palekar, S., Arias, M. A. F. M., Steinberg, S., Mulgoankar, S., Guasch, A., Sennesael, J., Yilmaz, S., Frei, U., Mendez, R., Alfrey, E., Yang, H., Areana, J., Shapiro, J., Stummvoll, H. K., Wright, F., Hart, M., Abramowicz, D., Neumayer, H. H., & Arns, W. (2006). Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic®). Clinical nephrology, 66(2), 103-111.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/86550

Budde, K., Knoll, G., Curtis, J., Chan, L., Pohanka, E., Gentil, M. Á. M., Seifu, Y., Marrast, A. C., Neumayer, H., Jones, J., Staffield-Coit, C., Copley, J. B. J., Pescovitz, M., Kahana, L., Halloran, P., Shoker, A. S. A., Danovitch, G., Pelletier, R., Salvadori, M., Weir, M., Flechner, S., Palekar, S., Arias, M. A. F. M., Steinberg, S., Mulgoankar, S., Guasch, A., Sennesael, J., Yilmaz, S., Frei, U., Mendez, R., Alfrey, E., Yang, H., Areana, J., Shapiro, J., Stummvoll, H. K., Wright, F., Hart, M., Abramowicz, D., Neumayer, H. H., & Arns, W. (2006). Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic®). Clinical nephrology, 66(2), 103-111.